Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000667535 | SCV000792004 | pathogenic | Fanconi anemia complementation group A | 2017-06-02 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000667535 | SCV002022304 | pathogenic | Fanconi anemia complementation group A | 2020-02-13 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001868216 | SCV002245821 | pathogenic | Fanconi anemia | 2023-08-02 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 552305). This premature translational stop signal has been observed in individual(s) with FANCA-related conditions (PMID: 22778927, 23613520). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Arg460*) in the FANCA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FANCA are known to be pathogenic (PMID: 19367192). |
Baylor Genetics | RCV000667535 | SCV004196602 | pathogenic | Fanconi anemia complementation group A | 2022-12-10 | criteria provided, single submitter | clinical testing |